Lista de obras -

Assessment of anti-donor T cell proliferation and cytotoxic T lymphocyte-mediated lympholysis in living donor kidney transplant patients

artículo científico publicado en 2014

Autologous mesenchymal stromal cells and kidney transplantation: a pilot study of safety and clinical feasibility.

artículo científico publicado en 2010

B Cell Reconstitution after Rituximab Treatment in Idiopathic Nephrotic Syndrome ⬇️

artículo científico publicado en 2015

Clinical Translation of Mesenchymal Stromal Cell Therapies in Nephrology.

artículo científico publicado en 2017

Complement activation: the missing link between ADAMTS-13 deficiency and microvascular thrombosis of thrombotic microangiopathies

artículo científico publicado en 2005

Cyclin-dependent kinase inhibition limits glomerulonephritis and extends lifespan of mice with systemic lupus

scholarly article by Carla Zoja et al published 2007 in Arthritis and Rheumatism

Effect of Timing and Complement Receptor Antagonism on Intragraft Recruitment and Protolerogenic Effects of Mesenchymal Stromal Cells in Murine Kidney Transplantation

scientific article published on 01 June 2019

Immunomodulatory effects of mesenchymal stromal cells in solid organ transplantation.

scientific article published on December 2010

In kidney transplant patients, alemtuzumab but not basiliximab/low-dose rabbit anti-thymocyte globulin induces B cell depletion and regeneration, which associates with a high incidence of de novo donor-specific anti-HLA antibody development.

artículo científico publicado en 2013

Individualized anticoagulation with dermatan sulphate for haemodialysis in chronic renal failure ⬇️

artículo científico publicado el 1 de noviembre de 1997

Kidney transplant tolerance associated with remote autologous mesenchymal stromal cell administration

artículo científico publicado en 2019

Localization of Mesenchymal Stromal Cells Dictates Their Immune or Proinflammatory Effects in Kidney Transplantation

artículo científico publicado en 2012

Long-Term Clinical and Immunological Profile of Kidney Transplant Patients Given Mesenchymal Stromal Cell Immunotherapy.

artículo científico publicado en 2018

Mesenchymal Stem Cells in Solid Organ Transplantation (MiSOT) Fourth Meeting: lessons learned from first clinical trials.

artículo científico publicado en 2013

Mesenchymal Stromal Cells for AKI after Cardiac Surgery.

artículo científico publicado en 2017

Mesenchymal Stromal Cells for Transplant Tolerance.

artículo científico publicado en 2019

Mesenchymal stromal cells and kidney transplantation: pretransplant infusion protects from graft dysfunction while fostering immunoregulation.

artículo científico publicado en 2013

Mesenchymal stromal cells for tolerance induction in organ transplantation

artículo científico publicado en 2017

Mesenchymal stromal cells in kidney transplantation

artículo científico publicado en 2019

Mesenchymal stromal cells in renal transplantation: opportunities and challenges.

artículo científico publicado en 2016

Mesenchymal stromal cells to control donor-specific memory T cells in solid organ transplantation

artículo científico publicado en 2015

Mesenchymal stromal cells to promote kidney transplantation tolerance.

artículo científico

Mesenchymal stromal cells to promote solid organ transplantation tolerance.

artículo científico publicado en 2013

Pluripotent stem cells and tolerance induction in organ transplantation.

artículo científico publicado en 2015

Recellularization of well-preserved acellular kidney scaffold using embryonic stem cells

artículo científico publicado en 2014

Recent advances in immunosuppression and acquired immune tolerance in renal transplants

artículo científico publicado en 2016

Regulatory T Cells and T Cell Depletion: Role of Immunosuppressive Drugs

artículo científico publicado en 2007

Renal prostacyclin biosynthesis is reduced in children with hemolytic-uremic syndrome in the context of systemic platelet activation

artículo científico publicado en 1992

Sirolimus versus cyclosporine therapy increases circulating regulatory T cells, but does not protect renal transplant patients given alemtuzumab induction from chronic allograft injury.

artículo científico publicado en 2007

The Toll-IL-1R Member Tir8/SIGIRR Negatively Regulates Adaptive Immunity against Kidney Grafts

artículo científico publicado en 2009

Update on mesenchymal stromal cell studies in organ transplant recipients

scientific article published on 01 February 2020

Vein Suturing Results in Worse Lung Graft Outcomes Compared to the Cuff Method

artículo científico publicado en 2019

Lista de obras de

Assessment of anti-donor T cell proliferation and cytotoxic T lymphocyte-mediated lympholysis in living donor kidney transplant patients

Autologous mesenchymal stromal cells and kidney transplantation: a pilot study of safety and clinical feasibility.

B Cell Reconstitution after Rituximab Treatment in Idiopathic Nephrotic Syndrome ⬇️

Clinical Translation of Mesenchymal Stromal Cell Therapies in Nephrology.

Complement activation: the missing link between ADAMTS-13 deficiency and microvascular thrombosis of thrombotic microangiopathies

Cyclin-dependent kinase inhibition limits glomerulonephritis and extends lifespan of mice with systemic lupus

Effect of Timing and Complement Receptor Antagonism on Intragraft Recruitment and Protolerogenic Effects of Mesenchymal Stromal Cells in Murine Kidney Transplantation

Immunomodulatory effects of mesenchymal stromal cells in solid organ transplantation.

In kidney transplant patients, alemtuzumab but not basiliximab/low-dose rabbit anti-thymocyte globulin induces B cell depletion and regeneration, which associates with a high incidence of de novo donor-specific anti-HLA antibody development.

Individualized anticoagulation with dermatan sulphate for haemodialysis in chronic renal failure ⬇️

Kidney transplant tolerance associated with remote autologous mesenchymal stromal cell administration

Localization of Mesenchymal Stromal Cells Dictates Their Immune or Proinflammatory Effects in Kidney Transplantation

Long-Term Clinical and Immunological Profile of Kidney Transplant Patients Given Mesenchymal Stromal Cell Immunotherapy.

Mesenchymal Stem Cells in Solid Organ Transplantation (MiSOT) Fourth Meeting: lessons learned from first clinical trials.

Mesenchymal Stromal Cells for AKI after Cardiac Surgery.

Mesenchymal Stromal Cells for Transplant Tolerance.

Mesenchymal stromal cells and kidney transplantation: pretransplant infusion protects from graft dysfunction while fostering immunoregulation.

Mesenchymal stromal cells for tolerance induction in organ transplantation

Mesenchymal stromal cells in kidney transplantation

Mesenchymal stromal cells in renal transplantation: opportunities and challenges.

Mesenchymal stromal cells to control donor-specific memory T cells in solid organ transplantation

Mesenchymal stromal cells to promote kidney transplantation tolerance.

Mesenchymal stromal cells to promote solid organ transplantation tolerance.

Pluripotent stem cells and tolerance induction in organ transplantation.

Recellularization of well-preserved acellular kidney scaffold using embryonic stem cells

Recent advances in immunosuppression and acquired immune tolerance in renal transplants

Regulatory T Cells and T Cell Depletion: Role of Immunosuppressive Drugs

Renal prostacyclin biosynthesis is reduced in children with hemolytic-uremic syndrome in the context of systemic platelet activation

Sirolimus versus cyclosporine therapy increases circulating regulatory T cells, but does not protect renal transplant patients given alemtuzumab induction from chronic allograft injury.

The Toll-IL-1R Member Tir8/SIGIRR Negatively Regulates Adaptive Immunity against Kidney Grafts

Update on mesenchymal stromal cell studies in organ transplant recipients

Vein Suturing Results in Worse Lung Graft Outcomes Compared to the Cuff Method